Logo
x

Search

Subscribe Now

novel

Takeda Signs a License Agreement with Genevant to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis

Takeda Signs a License Agreement with Genevant to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis

  • March 16, 2021
Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

  • December 21, 2020
Astellas Collaborates with KaliVir to Develop and Commercialize VET2-L2

Astellas Collaborates with KaliVir to Develop and Commercialize VET2-L2

  • December 8, 2020
Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

  • December 3, 2020
Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration with Takeda

Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration with Takeda

  • November 27, 2020
PostEra Collaborates with NeuroLucent to Identify Therapies for Alzheimer's Disease

PostEra Collaborates with NeuroLucent to Identify Therapies for Alzheimer's Disease

  • November 27, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.